Grifols SA files 20-F

Grifols, S.A. reported a consolidated net profit of EUR 500 million for the year ended December 31, 2025, a significant increase from EUR 213 million in 2024. This improvement was driven by strong performance in its Biopharma unit and efficient working capital management, despite an impairment loss on goodwill in its Alkahest unit and a write-off of an R&D project.